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Background: Although carbohydrate reduction of varying degrees is a popular and controversial dietary trend,
potential long-term effects for health, and cancer in specific, are largely unknown.
Methods: We studied a previously established low-carbohydrate, high-protein (LCHP) score in relation to the
incidence of cancer and specific cancer types in a population-based cohort in northern Sweden. Participants were
62,582 men and women with up to 17.8 years of follow-up (median 9.7), including 3,059 prospective cancer cases.
Cox regression analyses were performed for a LCHP score based on the sum of energy-adjusted deciles of
carbohydrate (descending) and protein (ascending) intake labeled 1 to 10, with higher scores representing a diet
lower in carbohydrates and higher in protein. Important potential confounders were accounted for, and the role of
metabolic risk profile, macronutrient quality including saturated fat intake, and adequacy of energy intake reporting
was explored.
Results: For the lowest to highest LCHP scores, 2 to 20, carbohydrate intakes ranged from median 60.9 to 38.9% of
total energy intake. Both protein (primarily animal sources) and particularly fat (both saturated and unsaturated)
intakes increased with increasing LCHP scores. LCHP score was not related to cancer risk, except for a non-dose
-dependent, positive association for respiratory tract cancer that was statistically significant in men. The multivariate
hazard ratio for medium (9–13) versus low (2–8) LCHP scores was 1.84 (95% confidence interval: 1.05-3.23; p-trend
= 0.38). Other analyses were largely consistent with the main results, although LCHP score was associated with
colorectal cancer risk inversely in women with high saturated fat intakes, and positively in men with higher LCHP
scores based on vegetable protein.
Conclusion: These largely null results provide important information concerning the long-term safety of moderate
carbohydrate reduction and consequent increases in protein and, in this cohort, especially fat intakes. In order to
determine the effects of stricter carbohydrate restriction, further studies encompassing a wider range of
macronutrient intakes are warranted.
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In recent years, low-carbohydrate diets have emerged as
a controversial and popular means of achieving weight
loss and controlling diabetes. In Sweden, extensive posi-
tive media support for dietary carbohydrate restriction
has occurred over the past 5–7 years [1]. During the
same time period, in northern Sweden, a complete* Correspondence: lena.nilsson@nutrires.umu.se
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reproduction in any medium, provided the orreversal of previous reductions in fat intake and choles-
terol levels has been reported in the general population
[2,3]. Discerning the potential long-term health effects
of carbohydrate restriction, not only of stringent
low-carbohydrate diets but also of more modest carbo-
hydrate reduction, is thus an important challenge in
nutrition research today.
For weight loss, low-carbohydrate diets, both ex-
tremely or more modestly reduced in carbohydrate
(e.g. E% carbohydrates/protein/fat = 9/28/63 [4], and 44/
18/38 [5], respectively) have been found to be at least asLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Nilsson et al. Nutrition Journal 2013, 12:58 Page 2 of 10
http://www.nutritionj.com/content/12/1/58effective as traditional low-calorie/low-fat diets over a
period of up to two years [5-7]. The results of random-
ized trials have also tended to support improved metabolic
parameters and blood lipids [8-11], but elevated markers
of stress and inflammation [11-13] in subjects following a
low-carbohydrate diet. These alterations might influence
the risk of major chronic diseases such as cardiovascular
disease and cancer [11,14]. However, from a long-term
perspective, the effects of carbohydrate reduction of vary-
ing degrees, and consequent increased consumption of
various types of protein and/or fat, for health outcomes,
and cancer in specific, are largely unknown.
The results of previous epidemiological studies in gen-
eral populations have suggested positive or null associa-
tions between low-carbohydrate diet scores, particularly
scores representing diets higher in foods of animal ori-
gin, and all-cause, cardiovascular, and cancer mortality
[15-19]. Prospective studies of cardiovascular disease
incidence have reported either an increased risk [20],
or reduced risk for plant-based [21], carbohydrate-
restricted diets. The only previous prospective study to
address overall cancer incidence found null associations
for both animal- and plant-based low-carbohydrate diets
[22]. An increased risk of incident breast cancer has
been observed for a dietary pattern characterized by a
low intake of bread and fruit juice and a high intake of
processed meat, fish, butter, other animal fats, and mar-
garine [23]. In contrast, a plant-based, low-carbohydrate
diet has been related to a reduced risk of estrogen-
receptor-negative breast cancer [24].
Given the high rates of overweight and obesity world-
wide, and the widespread popularity of low-carbohydrate
diets, evaluation of the long-term safety of carbohydrate re-
striction of varying degrees is crucial. The aim of the
present study was to investigate macronutrient distribution,
in particular a previously established low-carbohydrate,
high-protein (LCHP) score [16-20], in relation to the risk of
incident cancer and specific types of cancer in a large,
population-based cohort in northern Sweden.
Methods
Study design and cohort
The Västerbotten Intervention Programme (VIP) is an
ongoing, population-based, prospective cohort study and
health intervention, including residents of the northern
Swedish county of Västerbotten turning 40, 50 and
60 years of age. Until 1996, 30 year olds were also in-
cluded. The VIP protocol, described in detail elsewhere
[25,26], includes a health examination, with measure-
ment of a number of potential health risk factors, such
as an oral glucose tolerance test, as well as a participant-
administered diet and lifestyle questionnaire. For the
period assessed in this study, 1990–2007, the average
recruitment rate was 59% . The VIP food frequencyquestionnaire (FFQ) has been validated by 24-hour-recall
interviews [27], and by biomarkers in blood samples
collected from VIP participants [28,29]. Cancer inci-
dences comparable to those of the general population in
Västerbotten indicate a truly population-based cohort
[30], and no selection bias of importance has been dem-
onstrated [31].
As of December 31, 2007, when cases of incident can-
cer were identified for the present study, a total of
82,879 participation occasions (66,001 individuals) had
been registered within the VIP cohort. From these we
excluded 1,328 participation occasions with missing data
for more than 10% of the items in the FFQ and/or por-
tion size, 32 participation occasions with missing height
or weight data, 9 participation occasions with a body
mass index (BMI) <10, and 6,112 participation occasions
with food intake level (FIL) in the lowest 5th percentile
or the highest 2.5th percentile (specific to sex and FFQ
version and based on the first sampling occasion for
subjects with repeated measures), and 12,816 partici-
pants with more than one sampling occasion (most
recent sampling occasion excluded). The final study
population thus included 62,582 participants (31,397
men, 31,185 women).
Identification of cancer cases
A total of 3,059 incident, prospective cancer cases with-
out previous cancer diagnosis, except non-melanoma
skin cancer, were identified through linkage with the
regional branch of the national cancer registry, with site-
specific cancers defined according to the International
Classification of Diseases, ICD-7 [32], as follows: pros-
tate (177), breast (170), colorectum (153, 154.0), respira-
tory tract (161, 162), urinary tract (181), non-Hodgkin’s
lymphoma (200, 202), endometrium (172), malignant
melanoma (190), leukemia (204–207), pancreas (157),
ovary 175.0), stomach (151), multiple myeloma (203)
and renal cell (180.0, 180.9).
Low-carbohydrate, high-protein score
Dietary intake of macronutrients was calculated from
food frequency questionnaires with 9 fixed response
alternatives ranging from never to ≥4 times per day and
including 84 (years 1990–1996) or 65 (years 1997–2007)
food items, as well as photo-based portion-size estima-
tions for meat/fish, potatoes/pasta/rice, and vegetables
[26]. The 65-item FFQ was an abbreviated version of the
84-item FFQ, in which some food items had been
merged and some deleted as described elsewhere [33]
(p 26). All intake variables except ethanol were energy
adjusted according to the residual method [34].
Descending deciles, or tenths, of energy-adjusted
carbohydrate and ascending deciles of energy-adjusted
protein were labeled 1 to 10 and summed to create an
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previous studies [16-20]. The LCHP score is indepen-
dent of total energy intake, due to the isocaloric nature
of carbohydrate and protein, and it allows separate
consideration of the amount and quality of fat con-
sumed. LCHP scores were also categorized into low
(2–8 points), medium (9–13 points) and high (14–20
points), in order to approximate equally sized groups.
Statistical analyses
Differences in baseline characteristics of the study sub-
jects according to LCHP score category were determined
by the Kruskal-Wallis test. Spearman’s correlation coeffi-
cients were determined between LCHP score and intakes
of fat and saturated fat and sex-specific analyses were
done. Hazard ratios (HR) and 95% confidence intervals
(CI) for overall cancer incidence and for all types of
cancer with at least 50 cases were calculated by Cox pro-
portional hazard regression models. HR are presented
for medium and high versus low LCHP scores or per
1-point increase in LCHP score. p-trend were calculated
per 1-point increase in LCHP score. Age and BMI devi-
ated from the proportional hazard assumption according
to Schoenfeld’s test. Age was thus examined in 10-year
intervals, included as strata in the crude and multivariate
models, and BMI was dichotomized according to obesity
(BMI ≥30 kg/m2).
Of an extensive list of potential confounding variables,
only saturated fat intake altered any HR for LCHP by
more than 10% when included in a bivariate model. The
final multivariate model included age (10-year intervals,
strata), obesity (BMI ≥ 30 kg/m2, yes/no), sedentary life-
style (no physical activity in exercise clothes, yes/no),
education (lack of postsecondary, yes/no), current smok-
ing (yes/no), and intake of alcohol (g/day), saturated fat
(energy-adjusted residual), and total energy intake
(Kcal/day), all selected for their theoretical importance.
Missing data, present only for some categorical covari-
ates, i.e. education, N = 377 (0.6%), sedentary lifestyle,
N = 1,751 (2.8%), smoking, N = 706 (1.1%), were treated
as dummy variables.
Subgroup analyses were conducted for metabolic risk
profile, defined as at least one of, versus none of, obesity,
diabetes or impaired glucose tolerance. Diabetes was
defined as fasting plasma glucose ≥7.0 mmol/l and/or
post-load plasma glucose ≥12.2 mmol/l, and impaired
glucose tolerance was defined as fasting plasma glu-
cose ≥6.1 mmol/l and/or post-load plasma glucose
≥8.9 mmol/l. Subgroups based on saturated fat intake
(energy adjusted and stratified at the median) and energy
reporting (adequate versus inadequate, according to the
Goldberg cut-off, modified as described in our previous
report [19]) were also examined. The subgroup analyses
were limited to overall cancer incidence and cancerof the prostate, breast and colorectum, which were
the most common sites. Heterogeneity was tested by
Chi-square analysis. A sub-analysis was also performed
for the time period prior to the shift in macronutrient
intake in the VIP population [2] (follow-up to December
31, 2002). All tests were two-sided, and p-values <0.05
were considered statistically significant.
Ethical considerations
The study was approved by the Regional Ethical Review
Board of Northern Sweden (dossier number 07-165 M).
All study subjects provided written informed consent,
and the study was conducted in accordance with the
Declaration of Helsinki.
Results
Follow-up times ranged from 1 day to 17.9 years, me-
dian 9.7 years. Macronutrient intakes for the lowest to
highest LCHP scores (2–20 points) ranged from median
60.9 to 38.9% of total energy intake for carbohydrate,
11.3 to 18.9% for protein, and 26.7 to 41.5% for fat. Rela-
tionships between baseline characteristics and LCHP
score are presented in Table 1. High LCHP scores were
associated with younger age (not apparent in medians
due to sampling at 10-year age intervals) and higher
BMI, prevalence of current smokers, sedentary lifestyle
(women only) and alcohol intake. Lack of postsecondary
education was more common in men with low LCHP
scores and in women with high scores. LCHP scores
were positively related to intake of animal protein, but
negatively related to plant protein. For carbohydrate and
fat, associations were consistent in sucrose and whole
grain and saturated and unsaturated fat, respectively.
Spearman correlation coefficients for LCHP score and
energy-adjusted fat, saturated fat and unsaturated fat in-
takes were 0.51, 0.45, and 0.46, respectively.
There were no statistically significant associations be-
tween LCHP score and any cancer, with the exception of
an increased risk of respiratory tract cancer for medium
LCHP scores in men (multivariate HR for medium ver-
sus low LCHP scores 1.84; 95% CI 1.05-3.23; p-trend =
0.38) (Table 2). HR for high versus low LCHP scores for
respiratory tract cancer were above one in both men and
women, but not statistically significant.
Subgroup analyses based on metabolic risk profile, sat-
urated fat intake, and energy reporting [19], had no ma-
terial effects on results (Table 3). The only statistically
significant finding was an inverse association between
LCHP score and colorectal cancer risk in women with
high saturated fat intakes (multivariate HR for a 1-point
increase in LCHP score 0.92; 95% CI 0.87-0.98;
p = 0.013; p-heterogeneity = 0.003). Constructing LCHP
scores in which whole grain or sucrose replaced total
carbohydrates, and in which vegetable or animal protein
Table 1 Baseline characteristics of Västerbotten Intervention Programme participants according to low-carbohydrate,
high-protein (LCHP) score
n Low1, 2-8 n Medium1, 9-13 n High1, 14-20 p2
Men
Age at recruitment, years 9,811 50 (40–60) 12,909 50 (40–51) 8,677 40 (40–50) ≤0.001
Follow-up time, years 9,811 9.4 (6.4-12.7) 12,909 9.6 (6.1-12.8) 8,677 9.6 (5.2-13.1) 0.206
BMI, kg/m2 9,811 25.4 (23.7-27.5) 12,909 25.6 (23.8-27.8) 8,677 26.1 (24.1-28.4) ≤0.001
Current smokers 9,672 1,579 (16.3) 12,728 2,218 (17.4) 8,546 1,672 (19.6) ≤0.001
No postsecondary education 9,753 7,811 (80.1) 12,844 9,957 (77.5) 8,626 6,587 (76.4) ≤0.001
Sedentary lifestyle3 9,551 6,633 (69.4) 12,599 8,731 (69.3) 8,371 5,860 (70.0) 0.540
Energy intake, kcal/day 9,811 2,002 (1,672-2,397) 12,909 2,001 (1,667-2,410) 8,677 2,004 (1,672-2,415) 0.475
Ethanol intake, g/day 9,811 4.3 (1.1-7.5) 12,909 4.9 (1.8-8.3) 8,677 5.3 (2.2-8.6) ≤0.001
Carbohydrate intake,% of energy 9,811 53.5 (50.7-56.6) 12,909 48.1 (44.7-51.0) 8,677 43.6 (40.6-46.2) ≤0.001
Whole grain intake,% of energy 9,811 16.5 (12.2-30.0) 12,909 15.3 (11.1-19.7) 8,677 13.3 (9.4-17.3) ≤0.001
Sucrose intake,% of energy 9,811 8.3 (6.3-10.8) 12,909 6.2 (4.6-8.0) 8,677 4.8 (3.5-6.3) ≤0.001
Protein intake,% of energy 9,811 12.8 (11.9-13.7) 12,909 14.4 (13.3-15.4) 8,677 16.2 (15.3-17.3) ≤0.001
Animal protein intake,% of energy 9,811 8.3 (7.3-9.1) 12,909 10.2 (9.3-11.0) 8,677 12.4 (11.5-13.6) ≤0.001
Plant protein intake,% of energy 9,811 4.5 (3.9-5.2) 12,909 4.1 (3.5-4.7) 8,677 3.7 (3.2-4.2) ≤0.001
Fat intake,% of energy 9,811 32.7 (29.4-36.0) 12,909 36.7 (32.9-41.1) 8,677 39.4 (36.4-42.7) ≤0.001
Saturated fat intake,% of energy 9,811 13.5 (11.7-15.4) 12,909 15.4 (13.4-17.7) 8,677 16.6 (14.9-18.5) ≤0.001
Unsaturated fat intake,% of energy 9,811 18.9 (17.0-20.9) 12,909 21.1 (18.8-23.7) 8,677 22.6 (20.7-24.8) ≤0.001
Women
Age at recruitment, years 9,985 50 (40–60) 12,430 50 (40–50) 8,770 50 (40–50) ≤0.001
Follow-up time, years 9,985 9.7 (6.7-12.8) 12,430 9.9 (6.6-13.0) 8,770 9.9 (5.9-13.2) 0.206
BMI, kg/m2 9,985 24.4 (22.3-27.2) 12,430 24.4 (22.2-27.2) 8,770 24.7(22.4-27.8) ≤0.001
Current smokers 9,903 1,661 (16.8) 12,319 2,325 (18.9) 8,708 2,152 (24.7) ≤0.001
No postsecondary education 9,913 6,827 (68.9) 12,357 8,612 (69.7) 8,712 6,189 (71.0) 0.005
Sedentary lifestyle3 9,749 6,419 (65.8) 12,116 8,121 (67.0) 8,445 5,884 (69.7) ≤0.001
Energy intake, kcal/day 9,985 1,509 (1,273-1,787) 12,430 1,531 (1,294-1,815) 8,770 1,510 (1,268-1,806) ≤0.001
Ethanol intake, g/day 9,985 1.8 (0.1-3.4) 12,430 1.9 (0.2-3.8) 8,770 2.0 (0.2-4.0) ≤0.001
Protein intake,% of energy 9,985 13.4 (12.4-14.2) 12,430 14.9 (13.9-15.8) 8,770 16.7 (15.8-17.8) ≤0.001
Animal protein intake,% of energy 9,985 8.4 (7.5-9.3) 12,430 10.3 (9.5-11.1) 8,770 12.6 (11.6-13.7) ≤0.001
Plant protein intake,% of energy 9,985 4.9 (4.3-5.5) 12,430 4.5 (3.9-5.0) 8,770 4.1 (3.6-4.6) ≤0.001
Carbohydrate intake,% of energy 9,985 56.4 (53.8-59.3) 12,430 51.3 (48.3-53.8) 8,770 47.0 (44.2-49.4) ≤0.001
Whole grain intake,% of energy 9,985 18.4 (13.5-23.6) 12,430 16.7 (12.3-21.4) 8,770 14.4 (10.3-18.9) ≤0.001
Sucrose intake,% of energy 9,985 7.9 (6.2-10.0) 12,430 6.4 (5.0-7.9) 8,770 5.2 (4.0-6.6) ≤0.001
Fat intake,% of energy 9,985 29.1 (25.9-32.2) 12,430 33.0 (29.4-37.1) 8,770 35.5 (32.7-38.7) ≤0.001
Saturated fat intake,% of energy 9,985 11.8 (10.2-13.5) 12,430 13.7 (11.9-15.8) 8,770 14.9 (13.4-16.7) ≤0.001
Unsaturated fat intake,% of energy 9,985 17.1 (15.3-19.0) 12,430 19.1 (17.1-21.5) 8,770 20.4 (18.6-22.4) ≤0.001
1 LCHP scores were calculated separately for FFQ version and sex, and categorized into roughly equally sized groups: low (2–8 points), medium (9–13 points) and
high (14–20 points). Values are medians (25th, 75th percentiles) or frequencies (percents).
2 p-values were determined by the Kruskal-Wallis test.
3 Defined as no regular physical activity in exercise clothes.
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not differ from the main findings, except a statistically
significant increased risk of colorectal cancer in men
with higher LCHP scores based on vegetable protein
(multivariate HR for a 1-point increase in LCHP score1.07; 95% CI 1.01-1.14; p = 0.029; p-heterogeneity =
0.016).
In analyses restricted to the time period up to and in-
cluding December 31, 2002, there was a tendency to-
wards a positive association between high LCHP scores
Table 2 Associations between low-carbohydrate, high-protein (LCHP) score and incident all-cause and site-specific
cancer in Västerbotten Intervention Programme participants
Cancer type Sex LCHP
score1
n Model 12,3 Model 22,4
Cases HR (95% CI) p-trend5 HR (95% CI) p-trend5
All cancer sites Men low 545 1 1
n = 3,059 medium 650 1.12 (1.00-1.25) 1.10 (0.97-1.23)
high 327 1.01 (0.88-1.16) 0.678 0.97 (0.83-1.12) 0.973
Women low 525 1 1
medium 596 1.00 (0.89-1.13) 1.00 (0.89-1.13)
high 416 1.01 (0.89-1.15) 0.776 1.00 (0.86-1.15) 0.777
Prostate cancer Men low 256 1 1
n = 657 medium 266 1.02 (0.86-1.21) 1.01 (0.85-1.21)
high 135 0.98 (0.79-1.21) 0.671 0.97 (0.78-1.22) 0.588
Breast cancer Women low 195 1 1
n = 581 medium 232 1.03 (0.85-1.24) 1.04 (0.85-1.28)
high 154 0.96 (0.78-1.19) 0.761 1.00 (0.79-1.27) 0.924
<49 y at diagnosis Women low 30 1 1
n = 104 medium 49 1.15 (0.73-1.81) 1.26 (0.77-2.06)
high 25 0.85 (0.50-1.45) 0.948 1.04 (0.57-1.89) 0.343
>55 y at diagnosis Women low 73 1 1
n = 184 medium 71 1.03 (0.74-1.42) 1.07 (0.76-1.50)
high 40 0.96 (0.65-1.41) 0.975 1.02 (0.67-1.55) 0.707
Colorectum Men low 66 1 1
n = 329 medium 75 1.08 (0.78-1.51) 1.02 (0.72-1.44)
high 43 1.12 (0.76-1.65) 0.949 1.00 (0.66-1.52) 0.511
Women low 53 1 1
medium 58 1.02 (0.70-1.48) 0.99 (0.67-1.47)
high 34 0.88 (0.57-1.36) 0.625 0.83 (0.52-1.34) 0.459
Respiratory tract Men low 19 1 1
n = 143 medium 42 2.10 (1.22-3.61) 1.84 (1.05-3.23)
high 18 1.64 (0.86-3.14) 0.044 1.24 (0.62-2.47) 0.381
Women low 18 1 1
medium 27 1.38 (0.76-2.51) 1.42 (0.76-2.66)
high 19 1.39 (0.72-2.65) 0.261 1.37 (0.67-2.82) 0.328
Urinary tract Both sexes low 40 1 1
n = 116 medium 47 1.11 (0.73-1.69) 1.11 (0.72-1.73)
high 29 1.11 (0.69-1.81) 0.591 1.15 (0.68-1.94) 0.552
Non-Hodgkins lymphoma Both sexes low 44 1 1
n = 111 medium 40 0.83 (0.54-1.28) 0.92 (0.59-1.44)
high 27 0.90 (0.56-1.46) 0.902 1.10 (0.65-1.88) 0.400
Malignant melanoma Both sexes low 34 1 1
n = 105 medium 50 1.21 (0.78-1.87) 1.22 (0.77-1.93)
high 21 0.76 (0.44-1.31) 0.475 0.76 (0.42-1.37) 0.509
Endometrium Women low 30 1 1
n = 103 medium 41 1.25 (0.78-2.01) 1.35 (0.83-2.21)
high 32 1.42 (0.86-2.34) 0.268 1.60 (0.92-2.79) 0.161
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Table 2 Associations between low-carbohydrate, high-protein (LCHP) score and incident all-cause and site-specific
cancer in Västerbotten Intervention Programme participants (Continued)
Ovary Women low 24 1 1
n = 72 medium 28 1.03 (0.59-1.78) 1.01 (0.57-1.79)
high 20 1.07 (0.59-1.94) 0.710 0.99 (0.51-1.92) 0.927
Leukemia Both sexes low 25 1 1
n = 70 medium 23 0.82 (0.46-1.44) 0.78 (0.43-1.40)
high 22 1.20 (0.67-2.14) 0.476 1.14 (0.60-2.15) 0.601
Pancreas Both sexes low 25 1 1
n = 70 medium 28 1.03 (0.60-1.76) 0.88 (0.50-1.55)
high 17 0.99 (0.53-1.84) 0.771 0.77 (0.39-1.50) 0.584
Stomach Both sexes low 24 1 1
n = 69 medium 33 1.27 (0.75-2.16) 1.35 (0.78-2.35)
high 12 0.74 (0.37-1.49) 0.301 0.84 (0.40-1.79) 0.526
Multiple myeloma Both sexes low 23 1 1
n = 63 medium 29 1.13 (0.66-1.96) 0.94 (0.53-1.68)
high 11 0.68 (0.33-1.40) 0.692 0.51 (0.24-1.10) 0.211
Renal cell Both sexes low 21 1 1
n = 50 medium 21 0.92 (0.50-1.69) 0.89 (0.47-1.68)
high 8 0.56 (0.25-1.27) 0.174 0.54 (0.23-1.30) 0.162
1 LCHP scores were calculated separately for FFQ version and sex, and categorized into roughly equally sized groups: low (2–8 points), medium (9–13 points) and
high (14–20 points).
2 Hazard ratios were determined by Cox regression analyses.
3 Including age strata.
4 Further adjusted for obesity, sedentary lifestyle, lack of postsecondary education, current smoking, and intake of energy, alcohol, and saturated fat.
5 p-trend were calculated per 1-point increase in LCHP score.
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high versus low LCHP scores 1.25; 95% CI 0.86-1.80;
p-trend = 0.093) and women, (multivariate HR for high
versus low LCHP scores 1.39; 95% CI 0.98-1.96; p-trend
= 0.020) (Table 4). For prostate, breast and colorectal
cancers no significant associations were found.
Discussion
In this large population-based cohort study with a
follow-up period of up to 17.9 years, a diet moderately
low in carbohydrates and moderately high in protein
was largely unrelated to overall and site-specific cancer
incidence, regardless of the quantity and quality of fat
intake.
The one previous prospective study to report results
for overall cancer incidence, from the Iowa Women’s
Health Study, reported inverse risk relationships for
isocaloric substitution of either animal or vegetable pro-
tein for carbohydrates [22]. However, the results were
attenuated to null in multivariate analyses. Associations
reported for overall cancer mortality have also been null,
non-statistically significant, or unstable [15,17,19,22].
Taken together, the evidence to date does not support a
role for moderate carbohydrate reduction in determining
the overall risk of cancer.Increasing LCHP scores were associated with an ele-
vated risk of respiratory tract cancer in both men and
women in the present study, but the relationship was
not dose dependent and was only statistically significant
for medium LCHP scores in men. Although these obser-
vations may be due to chance or reflect residual
confounding due to smoking, they are consistent with a
previous finding for lung cancer mortality [15]. Further
study is therefore warranted.
There are several mechanisms by which a carbohy-
drate-reduced diet could influence carcinogenesis,
through specific food items or components, such as red
and processed meat for example [35], or through effects
on energy metabolism and body composition [36-39]. In
analyses considering macronutrient quality and meta-
bolic profile at baseline, two statistically significant re-
sults were observed, an inverse association between
LCHP score and colorectal cancer risk in women with
high saturated fat intakes, and an increased risk of colo-
rectal cancer in men with higher LCHP scores based on
vegetable protein. These findings do not support the hy-
pothesis that high animal protein intake increases the
risk for these cancer types. Previously, we have reported
a null association between LCHP score and colorectal
cancer mortality [19], and a positive association has been
Table 3 Associations between low-carbohydrate, high-protein (LCHP) score and incident all-cause and site-specific
cancer in subgroups of participants in the Västerbotten Intervention Programme based on metabolic risk profile,
saturated fat intake, and energy reporting
Cancer type Sex n Cases HR1 (95% CI) HR1 (95% CI) p-heterogeneity2
Metabolic risk profile3 low/high Low High
All cancer Men 1,251/371 1.00 (0.98-1.02) 0.99 (0.95-1.02) 0.668
Women 1,182/355 1.00 (0.98-1.02) 1.00 (0.97-1.03) 1.000
Prostate cancer Men 549/108 1.00 (0.97-1.02) 0.98 (0.93 -1.03) 0.513
Breast cancer Women 468/113 1.00 (0.97-1.02) 1.02 (0.97-1.07) 0.509
Colorectal cancer Men 142/42 0.98 (0.93-1.02) 1.02 (0.94-1.11) 0.419
Women 110/35 0.97 (0.92-1.02) 1.04 (0.95-1.14) 0.193
Saturated fat intake4 low/high Low High
All cancer Men 817/705 1.00 (0.99-1.02) 1.00 (0.98-1.01) 1.000
Women 845/692 1.01 (0.99-1.02) 1.00 (0.98-1.02) 0.493
Prostate cancer Men 375/282 1.01 (0.98-1.03) 0.99 (0.96-1.02) 0.363
Breast cancer Women 320/261 1.01 (0.98-1.04) 0.99 (0.96-1.02) 0.363
Colorectal cancer Men 89/95 1.00 (0.95-1.06) 0.97 (0.92-1.02) 0.418
Women 83/62 1.03 (0.98-1.09) 0.92 (0.87-0.98) 0.003
Energy reporting5 adequate/inadequate adequate inadequate
All cancer Men 548/846 1.00 (0.97-1.02) 1.00 (0.98-1.02)
Women 440/996 1.00 (0.98-1.03) 1.00 (0.98-1.01) 1.000
Prostate cancer Men 250/353 1.00 (0.97-1.03) 1.00 (0.97-1.03) 1.000
Breast cancer Women 192/360 0.98 (0.95-1.02) 1.01 (0.98-1.04) 1.000
Colorectal cancer Men 59/108 1.01 (0.94-1.08) 1.00 (0.94-1.04) 0.172
Women 33/103 1.03 (0.94-1.12) 0.96 (0.92-1.01) 0.837
1 Hazard ratios per 1-point increase in LCHP score, determined by Cox regression and adjusted for age strata, obesity, sedentary lifestyle, lack of postsecondary
education, current smoking, and intake of energy, alcohol, and saturated fat. Saturated fat intake was not included as a covariate in the subgroup analysis based
on saturated fat.
2 Comparison of subgroup HR by Chi-square test.
3 Metabolic risk profile defined as having at least one of (high), versus none of (low), obesity, diabetes or impaired glucose tolerance.
4 Stratified at sex-specific medians.
5 Defined according to the Goldberg cut-off, modified as described previously [19].
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colorectal cancer mortality [15]. The latter finding is
more consistent with the current understanding of the
role of diet in colorectal cancer. For example, there is
convincing evidence that a high consumption of protein
sources such as red and processed meat is associated
with increased colorectal cancer risk [35]. Furthermore,
in a controlled trial, a LCHP weight-loss diet has been
observed to reduce fecal cancer-protective metabolites
and increase hazardous metabolites, which could in-
crease the risk of colon cancer [40].
The limited variability in macronutrient distribution in
the study population may have prevented the detection
of associations with cancer risk. In particular, the role of
stricter carbohydrate restriction could not be assessed.
This is an issue common to both the present and previ-
ous studies [15,17,19,22]. Interindividual differences,
such as gene-nutrient interactions and epigenetics, both
emerging research fields [36], may also complicate therelationship between macronutrient distribution and
cancer risk. Furthermore, carbohydrate restriction might
have different roles in different stages of tumorigenesis,
making it difficult to detect overall effects on incidence.
For example, putative mechanisms for a role for carbo-
hydrate in the progression from premalignant lesion to
cancer diagnosis include metabolic reprogramming of
cancer cells resulting in increased glycolysis and glucose
requirements, the so-called Warburg effect, as well as
the stimulatory effect of insulin-like growth factor on
proliferating cells [37,41].
In northern Sweden, a rapid decline in fat intake
and hypercholesterolemia occurred between the years
1986–1992 [42], attributed in part to the cardiovascular
disease prevention activities of the VIP [42]. Today fat
intake has reached the peak levels of the 1980’s, and
carbohydrate intake is decreasing [2]. LCHP scores have
increased in VIP participants with repeated samples
10 years apart [19]. Furthermore, blood cholesterol
Table 4 Associations between low-carbohydrate, high-protein (LCHP) score and incident all-cause and site-specific
cancer in Västerbotten Intervention Programme participants in a subgroup with reduced follow-up until 2002
Cancer type Sex LCHP score1 n Cases Model 12,3 HR (95% CI) p-trend5 Model 22,4 HR (95% CI) p-trend5
All cancer sites Men low 94 1 1
n = 531 medium 118 1.20 (0.91-1.58) 1.35 (1.01-1.79)
high 55 1.05 (0.75-1.46) 0.599 1.25 (0.86-1.80) 0.093
Women low 82 1 1
medium 101 1.10 (0.81-1.47) 1.15 (0.84-1.56)
high 81 1.29 (0.95-1.76) 0.049 1.39 (0.98-1.96) 0.020
Prostate cancer Men low 47 1 1
n = 106 medium 40 0.86 (0.56-1.32) 0.98 (0.63-1.51)
high 19 0.80 (0.47-1.38) 0.261 1.01 (0.57-1.80) 0.871
Breast cancer Women low 29 1 1
n = 91 medium 33 0.98 (0.59-1.62) 1.05 (0.62-1.78)
high 29 1.24 (0.74-2.09) 0.210 1.38 (0.77-2.46) 0.100
Colorectum All low 17 1 1
n = 57 medium 24 1.38 (0.74-2.58) 1.48 (0.77-2.81)
high 16 1.58 (0.79-3.13) 0.320 1.76 (0.83-3.73) 0.245
1 LCHP scores were calculated separately for FFQ version and sex, and categorized into roughly equally sized groups: low (2–8 points), medium (9–13 points) and
high (14–20 points).
2 Hazard ratios were determined by Cox regression analyses.
3 Including age strata.
4 Further adjusted for obesity, sedentary lifestyle, lack of postsecondary education, current smoking, and intake of energy, alcohol, and saturated fat.
5 p-trend were calculated per 1-point increase in LCHP score.
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increasing, despite increasing use of cholesterol-lowering
drugs [3]. These temporal changes may have attenuated
our results, as indicated by the positive association be-
tween a high LCHP score and overall cancer incidence
in the sub-analysis restricted to the time period 1990–
2002, when LCHP score was relatively stable in the VIP
population. In the present study, roughly equal amounts
of saturated and unsaturated fat replaced most of the
carbohydrate reduction in subjects with high LCHP
scores, and the excess protein consumed by subjects
with high LCHP scores was primarily of animal origin.
In Sweden, extensive positive media focus for carbo-
hydrate-restricted diets in recent years has largely pro-
moted fat, often animal fat, rather than protein, as the
substitute for carbohydrates [1,43]. The general enthusi-
asm for carbohydrate reduction, and the apparent pref-
erence for animal-based replacement foods in Sweden,
thus underscores the importance of evaluating potential
long-term implications for health.
The main strengths of this study were the large,
population-based cohort, the extensive data available,
such as an oral glucose tolerance test and BMI measured
by health professionals, and the long, essentially
complete, follow-up. In addition, the prospective study
design reduced the risk of recall bias and reverse caus-
ation. We used an established LCHP score, which has
been employed in previous studies [16-18]. The LCHPscore does not include fat intake. However, unlike
macronutrient scores that incorporate fat, the LCHP
score is independent of total energy intake. It is also
simple, both to calculate and interpret, and it allowed
separate consideration of the amount and quality of fat
consumed. Food frequency questionnaires like the one
employed is this study have inherent weaknesses, such
as being a relatively inexact tool for the measurement of
total nutrient and energy intake, but they are generally
adequate for ranking and are an accepted and practical
tool for large-scale epidemiological studies. Although
several potential confounders were accounted for, re-
sidual confounding due to factors not measured (such as
food items not included in the FFQ) or not adequately
estimated (such as history of tobacco use) was likely
present. Since we consider this study to be exploratory,
the results were not corrected for multiple testing. The
risk of chance findings should therefore be acknowl-
edged. Numbers of cases were also low for some cancer
types and in some subgroup analyses.
Conclusion
In conclusion, the results of this population-based,
cohort study do not support an important role for a diet
moderately low in carbohydrates and moderately high in
protein, regardless of the quantity and quality of fat con-
sumed, in determining the overall, long-term risk of can-
cer, although a possible increased risk of respiratory
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general cancer risk over shorter time. Given the current
widespread popularity of carbohydrate-restricted diets,
and the limited data concerning potential long-term
health effects of carbohydrate reduction and consequent
increases in protein and/or fat intakes, these findings are
important. In order to evaluate the role of more strin-
gent carbohydrate restriction, investigations encompas-
sing a wider range of macronutrient intakes, such as
multicenter studies, will be needed.
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